New research shows diabetes drugs may significantly reduce the risk of dementia, Alzheimer's, and Parkinson’s disease.

Gliflozins, another name for sodium-glucose cotransporter-2 (SGLT2) inhibitors, were the subject of the investigation. By ...

A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, according to a new study.

A specific class of diabetes drug appears to lower people's risk for dementia and Parkinson's disease, a new study shows.

According to a new study, certain diabetes medications may significantly reduce this risk. These drugs, called gliflozins or ...

A Korean study published recently suggests people with type 2 diabetes who are prescribed a particular class of drug might be ...

A specific class of diabetes drug appears to lower people's risk for dementia and Parkinson's disease, a new study shows.

A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, according to a study ...

Sodium-glucose cotransporter-2 (SGLT2) inhibitors, a class of diabetes drugs also known as gliflozins, could lower the risk ...

Do you ever feel confused about your diabetes? Learning when and what to eat, why your blood sugar is high or low, when or ...